These sample data illustrate how phenotypic profiles can be used to tease out novel drug mechanisms. A team of Harvard scientists has found a high-throughput way to tie drugs with the cellular ...
In a recent study published in npj Antimicrobials and Resistance, researchers addressed the issue of the rise of antifungal drugs-resistant infections and the advent of multidrug-resistant fungal ...
A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing Food and Drug Administration (FDA) approved clinical trials reveals that CPI-613 is effective against most carcinoma cell ...
A first-in-class drug engineered to selectively inhibit the signaling pathway of the cannabinoid receptor CB1 has shown promise as a safe and effective treatment for cannabis use disorder (CUD). Tests ...
Dublin, July 07, 2020 (GLOBE NEWSWIRE) -- The "Europe Antibiotics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class; Action Mechanism; and Country" report has been added to ...
Health Affairs' Senior Deputy Editor Rob Lott interviews Jihye Han of Brigham and Women's Hospital and Harvard University on her recent paper that takes a closer look at the regulatory treatments for ...
A new experimental antibiotic can handily knock off one of the world’s most notoriously drug-resistant and deadly bacteria —in lab dishes and mice, at least. It does so with a never-before-seen method ...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/5c4kpn/global_bipolar) has announced the addition of the "Global Bipolar ...
The US Food and Drug Administration has approved Cobenfy, also known as KarXT, a new schizophrenia treatment. The drug was developed by Karuna Therapeutics, which was bought by Bristol Myers Squibb ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results